By
Neil Hodge2023-07-10T18:25:00
A former assistant commissioner of London’s Metropolitan Police Service has been announced as the next director of the U.K. Serious Fraud Office (SFO).
Nick Ephgrave will succeed Lisa Osofsky at the end of September for an initial five-year term.
Hopes are high his time in office will prove better than Osofsky’s, whose controversial tenure saw her failure to secure the prosecutions of several large companies and their directors (e.g., Tesco, G4S) and follow established legal procedure, resulting in the collapse of key cases (e.g., Serco, Unaoil).
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2024-04-22T13:00:00Z By Jeff Dale
The U.K.’s Serious Fraud Office said in a five-year strategic plan it’s “struggled to keep pace with demand” as ballooning casework shows no signs of slowing down.
2024-02-14T21:21:00Z By Kyle Brasseur
“Under my leadership, the SFO will be bolder, more pragmatic, more proactive,” said Nick Ephgrave in his first public speech as head of the U.K. Serious Fraud Office.
2023-12-06T20:00:00Z By Kyle Brasseur
The U.K. Serious Fraud Office launched a fraud investigation into AOG Technics over allegations the company supplied fake airplane engine parts to major airlines across the globe.
2026-01-22T17:32:00Z By Neil Hodge
Nick Ephgrave, director of the U.K.’s main anti-corruption enforcement agency, the Serious Fraud Office, will retire at the end of March—about halfway through his appointed five-year term. Experts say he leaves the agency in a lot better position than he joined it in September 2023.
2026-01-16T20:32:00Z By Oscar Gonzalez
The U.S. Federal Trade Commission finalized its order against General Motors and its OnStar subsidiary over the improper usage of geolocation and driving behavior data of drivers.
2026-01-16T17:49:00Z By Adrianne Appel
Kaiser Health affiliates have agreed to pay more than $556 million to settle allegations originally made by whistleblowers that they ignored compliance department warnings and unlawfully reworked diagnoses for Medicare patients in order to receive higher payments from the federal government.
Site powered by Webvision Cloud